Genetic Technologies Limited (GENE)
USD 0.77
(0.0%)
USD 0.77
(0.0%)
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 | 206.46 Thousand AUD | -36.65% |
| 2023 | 325.89 Thousand AUD | -18.15% |
| 2022 | 398.15 Thousand AUD | 417.57% |
| 2021 | 76.92 Thousand AUD | -15.83% |
| 2020 | 91.39 Thousand AUD | 186.8% |
| 2019 | 31.86 Thousand AUD | -46.0% |
| 2018 | 59 Thousand AUD | -23.19% |
| 2017 | 76.82 Thousand AUD | -53.98% |
| 2016 | 166.94 Thousand AUD | -47.42% |
| 2015 | 317.49 Thousand AUD | 49.06% |
| 2014 | 212.99 Thousand AUD | -0.37% |
| 2013 | 213.79 Thousand AUD | -32.5% |
| 2012 | 316.71 Thousand AUD | -33.13% |
| 2011 | 473.65 Thousand AUD | 59.01% |
| 2010 | 297.87 Thousand AUD | -46.2% |
| 2009 | 553.65 Thousand AUD | -35.55% |
| 2008 | 859.06 Thousand AUD | 57.96% |
| 2007 | 543.84 Thousand AUD | -7.54% |
| 2006 | 588.18 Thousand AUD | 58818500.0% |
| 2005 | 1.00 AUD | 0.0% |
| 2004 | - AUD | -100.0% |
| 2003 | 258.34 Thousand AUD | -66.96% |
| 2002 | 781.81 Thousand AUD | -68.19% |
| 2001 | 2.45 Million AUD | -39.81% |
| 2000 | 4.08 Million AUD | 0.0% |
| Year | Inventory | Inventory Growth |
|---|---|---|
| 2024 Q2 | 396.7 Thousand AUD | 0.0% |
| 2024 Q1 | 396.7 Thousand AUD | 21.73% |
| 2024 FY | 206.46 Thousand AUD | -36.65% |
| 2024 Q4 | 206.46 Thousand AUD | 0.0% |
| 2024 Q3 | 206.46 Thousand AUD | -47.95% |
| 2023 Q3 | 325.89 Thousand USD | -19.47% |
| 2023 Q4 | 325.89 Thousand AUD | 0.0% |
| 2023 FY | 325.89 Thousand AUD | -18.15% |
| 2023 Q1 | 404.67 Thousand USD | 1.64% |
| 2023 Q2 | 404.67 Thousand AUD | 0.0% |
| 2022 FY | 398.15 Thousand AUD | 417.57% |
| 2022 Q2 | 334.6 Thousand AUD | 0.0% |
| 2022 Q3 | 398.15 Thousand AUD | 18.99% |
| 2022 Q4 | 398.15 Thousand AUD | 0.0% |
| 2022 Q1 | 334.6 Thousand AUD | 334.96% |
| 2021 Q3 | 76.92 Thousand AUD | -32.56% |
| 2021 Q1 | 114.06 Thousand AUD | 24.82% |
| 2021 Q2 | 114.06 Thousand AUD | 0.0% |
| 2021 FY | 76.92 Thousand AUD | -15.83% |
| 2021 Q4 | 76.92 Thousand AUD | 0.0% |
| 2020 FY | 91.39 Thousand AUD | 186.8% |
| 2020 Q1 | 76.52 Thousand AUD | 140.14% |
| 2020 Q2 | 76.52 Thousand AUD | 0.0% |
| 2020 Q3 | 91.39 Thousand AUD | 19.43% |
| 2020 Q4 | 91.39 Thousand AUD | 0.0% |
| 2019 Q2 | - AUD | 0.0% |
| 2019 Q3 | 31.86 Thousand AUD | 0.0% |
| 2019 Q1 | - AUD | -100.0% |
| 2019 Q4 | 31.86 Thousand AUD | 0.0% |
| 2019 FY | 31.86 Thousand AUD | -46.0% |
| 2018 Q2 | - AUD | 0.0% |
| 2018 FY | 59 Thousand AUD | -23.19% |
| 2018 Q4 | 59 Thousand AUD | 0.0% |
| 2018 Q3 | 59 Thousand AUD | 0.0% |
| 2018 Q1 | - AUD | -100.0% |
| 2017 Q2 | 1.00 AUD | 0.0% |
| 2017 FY | 76.82 Thousand AUD | -53.98% |
| 2017 Q4 | 76.82 Thousand AUD | 0.0% |
| 2017 Q3 | 76.82 Thousand AUD | 7682100.0% |
| 2017 Q1 | 1.00 AUD | -100.0% |
| 2016 Q3 | 166.94 Thousand AUD | 0.0% |
| 2016 FY | 166.94 Thousand AUD | -47.42% |
| 2016 Q1 | - AUD | -100.0% |
| 2016 Q4 | 166.94 Thousand AUD | 0.0% |
| 2016 Q2 | - AUD | 0.0% |
| 2015 Q3 | 317.49 Thousand AUD | 5.03% |
| 2015 FY | 317.49 Thousand AUD | 49.06% |
| 2015 Q2 | 302.28 Thousand AUD | 30228000.0% |
| 2015 Q4 | 317.49 Thousand AUD | 0.0% |
| 2015 Q1 | 1.00 AUD | -100.0% |
| 2014 Q3 | 212.99 Thousand AUD | -54.92% |
| 2014 FY | 212.99 Thousand AUD | -0.37% |
| 2014 Q2 | 472.44 Thousand AUD | 47244700.0% |
| 2014 Q1 | 1.00 AUD | -100.0% |
| 2014 Q4 | 212.99 Thousand AUD | 0.0% |
| 2013 Q3 | 213.79 Thousand AUD | 21379000.0% |
| 2013 Q1 | 1.00 AUD | -100.0% |
| 2013 Q4 | 213.79 Thousand AUD | 0.0% |
| 2013 FY | 213.79 Thousand AUD | -32.5% |
| 2013 Q2 | 1.00 AUD | 0.0% |
| 2012 Q2 | - AUD | 0.0% |
| 2012 FY | 316.71 Thousand AUD | -33.13% |
| 2012 Q4 | 316.71 Thousand AUD | 0.0% |
| 2011 Q4 | 473.65 Thousand AUD | 0.0% |
| 2011 FY | 473.65 Thousand AUD | 59.01% |
| 2011 Q2 | 291.09 Thousand AUD | 0.0% |
| 2010 Q4 | 369.53 Thousand AUD | 0.0% |
| 2010 FY | 297.87 Thousand AUD | -46.2% |
| 2010 Q2 | - AUD | 0.0% |
| 2009 Q4 | - AUD | 0.0% |
| 2009 FY | 553.65 Thousand AUD | -35.55% |
| 2009 Q2 | 445.08 Thousand AUD | 0.0% |
| 2008 FY | 859.06 Thousand AUD | 57.96% |
| 2008 Q4 | 859.06 Thousand AUD | 0.0% |
| 2008 Q2 | 720.77 Thousand AUD | 0.0% |
| 2007 Q4 | 543.84 Thousand AUD | 0.0% |
| 2007 FY | 543.84 Thousand AUD | -7.54% |
| 2007 Q2 | 321.1 Thousand AUD | 0.0% |
| 2006 Q4 | 588.18 Thousand AUD | 0.0% |
| 2006 Q2 | 600.15 Thousand AUD | 0.0% |
| 2006 FY | 588.18 Thousand AUD | 58818500.0% |
| 2005 Q4 | 1.00 AUD | 0.0% |
| 2005 FY | 1.00 AUD | 0.0% |
| 2005 Q2 | 1.00 AUD | 0.0% |
| 2004 FY | - AUD | -100.0% |
| 2003 FY | 258.34 Thousand AUD | -66.96% |
| 2002 FY | 781.81 Thousand AUD | -68.19% |
| 2001 FY | 2.45 Million AUD | -39.81% |
| 2000 FY | 4.08 Million AUD | 0.0% |
| Name | Inventory | Inventory Difference |
|---|---|---|
| Bionano Genomics, Inc. | 22.89 Million USD | 99.098% |
| iSpecimen Inc. | - USD | -Infinity% |
| Prenetics Global Limited | 3.12 Million USD | 93.397% |
| OpGen, Inc. | 1.00 USD | -20646700.0% |
| Exact Sciences Corporation | 127.47 Million USD | 99.838% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 93.963% |
| CareDx, Inc | 19.47 Million USD | 98.94% |
| Exagen Inc. | 2.87 Million USD | 92.808% |
| Inotiv, Inc. | 56.1 Million USD | 99.632% |
| Guardant Health, Inc. | 61.94 Million USD | 99.667% |
| Biodesix, Inc. | 1.4 Million USD | 85.252% |
| BioNexus Gene Lab Corp. | 1.13 Million USD | 81.853% |
| Precipio, Inc. | 384 Thousand USD | 46.232% |
| Aspira Women's Health Inc. | 227 Thousand USD | 9.045% |
| Standard BioTools Inc. | 20.53 Million USD | 98.994% |
| 23andMe Holding Co. | 12.46 Million USD | 98.344% |
| Castle Biosciences, Inc. | 7.94 Million USD | 97.4% |
| Personalis, Inc. | 5.66 Million USD | 96.353% |
| Aclaris Therapeutics, Inc. | - USD | -Infinity% |
| Applied DNA Sciences, Inc. | 330.02 Thousand USD | 37.439% |
| T2 Biosystems, Inc. | 4.81 Million USD | 95.716% |
| Neogen Corporation | 189.26 Million USD | 99.891% |
| Natera, Inc. | 40.75 Million USD | 99.493% |
| Myriad Genetics, Inc. | 20.1 Million USD | 98.973% |
| ICON Public Limited Company | 1.00 USD | -20646700.0% |
| NeoGenomics, Inc. | 24.15 Million USD | 99.145% |
| Star Equity Holdings, Inc. | 3.42 Million USD | 93.963% |
| IDEXX Laboratories, Inc. | 380.28 Million USD | 99.946% |
| RadNet, Inc. | 1.00 USD | -20646700.0% |
| MDxHealth SA | 2.77 Million USD | 92.57% |
| Check-Cap Ltd. | - USD | -Infinity% |
| Twist Bioscience Corporation | 32.06 Million USD | 99.356% |
| Psychemedics Corporation | 1.00 USD | -20646700.0% |
| Fulgent Genetics, Inc. | 5.82 Million USD | 96.457% |
| Sera Prognostics, Inc. | - USD | -Infinity% |
| OPKO Health, Inc. | 65.69 Million USD | 99.686% |
| Illumina, Inc. | 587 Million USD | 99.965% |
| DarioHealth Corp. | 5.06 Million USD | 95.921% |
| ENDRA Life Sciences Inc. | 2.62 Million USD | 92.128% |
| Medpace Holdings, Inc. | 1.00 USD | -20646700.0% |
| Prenetics Global Limited | 3.12 Million USD | 93.397% |
| Intelligent Bio Solutions Inc. | 777.53 Thousand USD | 73.446% |
| Mainz Biomed B.V. | 613.63 Thousand USD | 66.353% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -1017.009% |
| Trinity Biotech plc | 19.93 Million USD | 98.964% |
| Neuronetics, Inc. | 8.09 Million USD | 97.449% |
| Sotera Health Company | 51.98 Million USD | 99.603% |
| bioAffinity Technologies, Inc. | 18.48 Thousand USD | -1017.009% |